Swaraj and pharmaceutical industry

Aug 03, Sushma Swaraj India and Kazakhstan today agreed to further strengthen defence cooperation as External Affairs Minister Sushma Swaraj met the country's top leaders to discuss ways to consolidate the strategic partnership in areas like trade, energy, security and information technology.

Swaraj and pharmaceutical industry

After a two-year delay, a mandatory marketing code for the pharmaceutical industry to stop Swaraj and pharmaceutical industry bribing of doctors and health professionals may soon come into force.

Jul 15, The pharmaceuticals department DoP earlier this week sent the draft Essential Commodities Control of Unethical Practices in Marketing of Drugs Order to the law ministry for final clearance. Asked whether the usual day period of the draft being put in the public domain for comments would be waived, the official said, "In this case, all stakeholders have already been consulted extensively, so that may not be needed".

The draft specifies July 1 as the date for the order to come into force, a deadline already missed. But the newly proposed order states that it will not apply to medical devices, an industry worth over Rs 25, crore per year.

This is because a separate code is being drafted for the medical device industry. That code will be voluntary for six months though the government admits that voluntary codes do not work.

The draft order on controlling unethical marketing practices in pharma prohibits companies from offering cash, gifts and sponsorship or providing travel facility or paid vacations for doctors, chemists and pharmacists. However, it allows the sponsorship of academic conferences organised by medical associations and screening camps or awareness campaigns to be organised in government-owned healthcare facilities, while stipulating that these cannot be used as surrogate advertising.

All complaints regarding violations are to be looked into by "an officer not below the rank of joint secretary" appointed by the government as the ethics compliance officer.

India, Kazakhstan agree to further strengthen defence cooperation - The Economic Times

However, it is not clear whether the pharma company itself or its agent would be held liable for violations. Where a company is found liable, the penalty extends from suspension of marketing for a period of three months to one year depending on the seriousness of the violation.

Suspension of marketing would apply to the brand of drug of the violating company with the "highest moving annual turnover for the preceding 12 months" or the highest selling brand of the company.

Or, the companies could apply to commute the marketing suspension by paying a penalty ranging from Rs 5 lakh to Rs 10 lakh. The appellate authority will be the DoP secretary, after which the company could go to court.

Swaraj and pharmaceutical industry

Experts TOI spoke to pointed out that giving companies the option of paying their way out of a marketing suspension could convert the penalty system into just another cost of doing business.

This could dent the deterrence value of the regulation.It is our responsibility to maintain this 'Swaraj' with 'Suraaj'," he said. This day in , Netaji Subhas Chandra Bose established the provincial Azad Hind government in Singapore.

Our organization engages in offering a comprehensive range of Nylon Turrets, which is made available at industry leading prices. The spare parts supplied in this range are extensively used in the pharmaceutical sector, in machines meant for formulating medicines and tablets. The official visit will also see Cassis discuss with his Indian counterpart Sushma Swaraj a free trade deal between India and the European Free Trade Association (EFTA), of which Switzerland is a.

Swaraj is on a three-nation tour to Kazakhstan, Kyrgyzstan and Uzbekistan to boost strategic partnership with central Asian nations. Never miss a great news story! pharmaceutical industry. central asia. kazakhstan. Uzbekistan. Also Read. India, Kazakhstan agree to ramp up military ties.

Hier ein kleiner Vorgeschmack darauf, was LinkedIn Mitglieder ├╝ber Swaraj Gupta sagen: Both of us worked for a management consulting client for around 2 years and on projects. He is a great performer and completes his tasks giving excellent results on time, every time and with great timberdesignmag.com: Consultant at McKinsey & Company.

Experts in the pharmaceutical industry said that if spending on new drug discovery was increased to the desired level, domestic firms could corner major share .

Swaraj Engines (Update): A compounding story, with high return ratios. Maintain BUY